JPRN-UMIN000011667Completed未知
Prevention of postoperative VTE using Enoxaparin in laparoscopic gastrectomy and colectomy for malignancies. - Prevention of postoperative VTE using Enoxaparin in laparoscopic gastrectomy and colectomy for malignancies.
Gastroenterological Surgery 1 Hokkaido Univ. Graduated School of Medicine0 sites450 target enrollmentStarted: October 1, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 450
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 40years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)Patients with heparin-induced thrombocytopenia or patients with a history of hypersensitivity of to heparin or related substances(HIT). 2)Patients with acute bacterial endocarditis 3)Patients with severe to moderate renal dysfunction(creatinine clearance below 50mL/min). 4)Patients with severe liver failure. 5)Low-weight patients (weight less than 40kg) 6)Women who may possibly be pregnant or are pregnant. 7)Patients receiving antiplatelet drugs (such as clopidogrel or aspirin) or anticoagulant drugs (warfarin etc.) affecting hemostasis preoperatively. 8)Patients with venous thromboembolic disease was observed within one year prior to surgery of this study or the patient with clinical signs or merger of deep vein thrombosis. 9)Ppatients with contraindications of iodinated contrast agent. 10)Patients who have indwelling central venous catheter. 11)Patients treated with progesterone and estrogen formulation within 4 weeks before administration. 12)Patients receiving radiation therapy or systemic cancer chemotherapy within two weeks before the administration. 13)Patients is determined inappropriate as a test target by principal investigator.
Investigators
Similar Trials
Completed
Phase 1
Comparison of two drug thinning agents (unfractionated heparin and low-molecular weight heparin) for prevention of stroke after brain aneurysm treatment utilizing coils or stentsIntracranial AneurysmACTRN12616001277437Royal Brisbane and Women's Hospital154
Recruiting
Phase 2
Safety and efficacy of postoperative enoxaparin treatment in patients undergoing curative hepatobiliary-pancreatic cancer surgery: a prospective, Phase Two, multi-center studyhepatobiliary-pancreatic cancerJPRN-UMIN000019368Department of Surgery, Osaka University Graduate School of Medicine260
Completed
Phase 4
EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged ImmobilizationVenous ThromboembolismNCT00077753Sanofi4,726
Completed
Phase 4
PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)Acute Ischemic StrokeNCT00077805Sanofi
Completed
Not Applicable
The EPPI Trial – Enoxaparin for the Prevention of Preeclampsia and Intrauterine growth restriction – a pilot randomised open-label trial.Intrauterine growth restrictionACTRN12609000699268niversity of Auckland160